Cellda AB
The startup develops computer image analysis software that utilizes automated clinical analysis technology to identify prostate cancer cases through antibody staining. This technology enables the rapid exclusion of normal prostate biopsies from further examination, facilitating quicker and more accurate histopathological diagnoses while reducing healthcare costs.
- Artificial Intelligence
- Data & Analytics
- Digital Health
- Healthcare Technology
- Software Only
Updated 6 months ago
Funding
Raised to date
$940KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops computer image analysis software that utilizes automated clinical analysis technology to identify prostate cancer cases through antibody staining. This technology enables the rapid exclusion of normal prostate biopsies from further examination, facilitating quicker and more accurate histopathological diagnoses while reducing healthcare costs.